Home > > > Report Detail

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 08-Jul-2019
No. of pages: 91
Inquire Before Buying

Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to genetic alteration of the cells and therefore causing uncontrolled growth and forming tumor like structure. Imaging is the preferred method of cancer detection but cannot have genetic access; on the other hand biopsies which have genetic access are complicated and difficult to perform repetitively during the course of cancer diagnosis and therapy. Therefore newer techniques developed in lines with non invasive diagnosis such as molecular diagnosis, serum based immunoassays and chemical tests to identify chemical components in the body especially from blood and urine. All these procedures are performed either with non-surgical or minimal surgical procedures; therefore these non-invasive cancer diagnostic techniques are becoming more and more popular among healthcare practitioners.

In 2018, the global Noninvasive Cancer Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Noninvasive Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Noninvasive Cancer Diagnostics development in United States, Europe and China.

The key players covered in this study

- Precision Therapeutics, Inc. (U.S.)

- A&G Pharmaceutical, Inc. (U.S.)

- Affymetrix Inc. (U.S.)

- AVIVA Biosciences Corporation (U.S.)

- BIOVIEW Inc. (U.S.)

- Laboratory Corporation of America Holdings (LabCorp) (U.S.)

- Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)

- Digene Corporation (U.S.)

- Gen-Probe Incorporated (U.S.)

- IVDiagnostics, Inc. (U.S.)

Market segment by Type, the product can be split into

- Clinical Chemistry

- Immunochemistry/Immunoassay

- Molecular Diagnostics

- Others

Market segment by Application, split into

- Solid Tumors

- Blood Cancer

- Lung Cancer

- Breast Cancer

- Others

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Noninvasive Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.

- To present the Noninvasive Cancer Diagnostics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Noninvasive Cancer Diagnostics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Clinical Chemistry
1.4.3 Immunochemistry/Immunoassay
1.4.4 Molecular Diagnostics
1.4.5 Others
1.5 Market by Application
1.5.1 Global Noninvasive Cancer Diagnostics Market Share by Application (2014-2025)
1.5.2 Solid Tumors
1.5.3 Blood Cancer
1.5.4 Lung Cancer
1.5.5 Breast Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Noninvasive Cancer Diagnostics Market Size
2.2 Noninvasive Cancer Diagnostics Growth Trends by Regions
2.2.1 Noninvasive Cancer Diagnostics Market Size by Regions (2014-2025)
2.2.2 Noninvasive Cancer Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Noninvasive Cancer Diagnostics Market Size by Manufacturers
3.1.1 Global Noninvasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Noninvasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Noninvasive Cancer Diagnostics Key Players Head office and Area Served
3.3 Key Players Noninvasive Cancer Diagnostics Product/Solution/Service
3.4 Date of Enter into Noninvasive Cancer Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Noninvasive Cancer Diagnostics Market Size by Type (2014-2019)
4.2 Global Noninvasive Cancer Diagnostics Market Size by Application (2014-2019)
5 United States
5.1 United States Noninvasive Cancer Diagnostics Market Size (2014-2019)
5.2 Noninvasive Cancer Diagnostics Key Players in United States
5.3 United States Noninvasive Cancer Diagnostics Market Size by Type
5.4 United States Noninvasive Cancer Diagnostics Market Size by Application
6 Europe
6.1 Europe Noninvasive Cancer Diagnostics Market Size (2014-2019)
6.2 Noninvasive Cancer Diagnostics Key Players in Europe
6.3 Europe Noninvasive Cancer Diagnostics Market Size by Type
6.4 Europe Noninvasive Cancer Diagnostics Market Size by Application
7 China
7.1 China Noninvasive Cancer Diagnostics Market Size (2014-2019)
7.2 Noninvasive Cancer Diagnostics Key Players in China
7.3 China Noninvasive Cancer Diagnostics Market Size by Type
7.4 China Noninvasive Cancer Diagnostics Market Size by Application
8 Japan
8.1 Japan Noninvasive Cancer Diagnostics Market Size (2014-2019)
8.2 Noninvasive Cancer Diagnostics Key Players in Japan
8.3 Japan Noninvasive Cancer Diagnostics Market Size by Type
8.4 Japan Noninvasive Cancer Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Noninvasive Cancer Diagnostics Market Size (2014-2019)
9.2 Noninvasive Cancer Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Noninvasive Cancer Diagnostics Market Size by Type
9.4 Southeast Asia Noninvasive Cancer Diagnostics Market Size by Application
10 India
10.1 India Noninvasive Cancer Diagnostics Market Size (2014-2019)
10.2 Noninvasive Cancer Diagnostics Key Players in India
10.3 India Noninvasive Cancer Diagnostics Market Size by Type
10.4 India Noninvasive Cancer Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Noninvasive Cancer Diagnostics Market Size (2014-2019)
11.2 Noninvasive Cancer Diagnostics Key Players in Central & South America
11.3 Central & South America Noninvasive Cancer Diagnostics Market Size by Type
11.4 Central & South America Noninvasive Cancer Diagnostics Market Size by Application
12 International Players Profiles
12.1 Precision Therapeutics, Inc. (U.S.)
12.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Noninvasive Cancer Diagnostics Introduction
12.1.4 Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.1.5 Precision Therapeutics, Inc. (U.S.) Recent Development
12.2 A&G Pharmaceutical, Inc. (U.S.)
12.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Noninvasive Cancer Diagnostics Introduction
12.2.4 A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Development
12.3 Affymetrix Inc. (U.S.)
12.3.1 Affymetrix Inc. (U.S.) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Noninvasive Cancer Diagnostics Introduction
12.3.4 Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.3.5 Affymetrix Inc. (U.S.) Recent Development
12.4 AVIVA Biosciences Corporation (U.S.)
12.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Noninvasive Cancer Diagnostics Introduction
12.4.4 AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.4.5 AVIVA Biosciences Corporation (U.S.) Recent Development
12.5 BIOVIEW Inc. (U.S.)
12.5.1 BIOVIEW Inc. (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Noninvasive Cancer Diagnostics Introduction
12.5.4 BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.5.5 BIOVIEW Inc. (U.S.) Recent Development
12.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
12.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Noninvasive Cancer Diagnostics Introduction
12.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
12.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
12.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Noninvasive Cancer Diagnostics Introduction
12.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
12.8 Digene Corporation (U.S.)
12.8.1 Digene Corporation (U.S.) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Noninvasive Cancer Diagnostics Introduction
12.8.4 Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.8.5 Digene Corporation (U.S.) Recent Development
12.9 Gen-Probe Incorporated (U.S.)
12.9.1 Gen-Probe Incorporated (U.S.) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Noninvasive Cancer Diagnostics Introduction
12.9.4 Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.9.5 Gen-Probe Incorporated (U.S.) Recent Development
12.10 IVDiagnostics, Inc. (U.S.)
12.10.1 IVDiagnostics, Inc. (U.S.) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Noninvasive Cancer Diagnostics Introduction
12.10.4 IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)
12.10.5 IVDiagnostics, Inc. (U.S.) Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Noninvasive Cancer Diagnostics Key Market Segments
Table Key Players Noninvasive Cancer Diagnostics Covered
Table Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Noninvasive Cancer Diagnostics Market Size Market Share by Type 2014-2025
Figure Clinical Chemistry Figures
Table Key Players of Clinical Chemistry
Figure Immunochemistry/Immunoassay Figures
Table Key Players of Immunochemistry/Immunoassay
Figure Molecular Diagnostics Figures
Table Key Players of Molecular Diagnostics
Figure Others Figures
Table Key Players of Others
Table Global Noninvasive Cancer Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Solid Tumors Case Studies
Figure Blood Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Others Case Studies
Figure Noninvasive Cancer Diagnostics Report Years Considered
Table Global Noninvasive Cancer Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Noninvasive Cancer Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Share by Regions 2014-2019
Figure Global Noninvasive Cancer Diagnostics Market Share by Regions 2014-2019
Figure Global Noninvasive Cancer Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Noninvasive Cancer Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Noninvasive Cancer Diagnostics Market Share by Manufacturers in 2018
Table Global Noninvasive Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Noninvasive Cancer Diagnostics Product/Solution/Service
Table Date of Enter into Noninvasive Cancer Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Size Share by Type (2014-2019)
Figure Global Noninvasive Cancer Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Noninvasive Cancer Diagnostics Market Size Share by Application (2014-2019)
Figure Global Noninvasive Cancer Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Noninvasive Cancer Diagnostics Revenue Market Share by Application in 2018
Figure United States Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table United States Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table United States Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure Europe Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table Europe Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table Europe Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure China Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table China Noninvasive Cancer Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table China Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure Japan Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table Japan Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table Japan Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table Southeast Asia Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure India Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table India Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table India Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Noninvasive Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Noninvasive Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Noninvasive Cancer Diagnostics Market Share (2018-2019)
Table Central & South America Noninvasive Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Noninvasive Cancer Diagnostics Market Share by Type (2014-2019)
Table Central & South America Noninvasive Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Noninvasive Cancer Diagnostics Market Share by Application (2014-2019)
Table Precision Therapeutics, Inc. (U.S.) Company Details
Table Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019) (Million US$)
Figure Precision Therapeutics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Precision Therapeutics, Inc. (U.S.) Recent Development
Table A&G Pharmaceutical, Inc. (U.S.) Company Details
Table A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure A&G Pharmaceutical, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table A&G Pharmaceutical, Inc. (U.S.) Recent Development
Table Affymetrix Inc. (U.S.) Company Details
Table Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Affymetrix Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Affymetrix Inc. (U.S.) Recent Development
Table AVIVA Biosciences Corporation (U.S.) Company Details
Table AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure AVIVA Biosciences Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table AVIVA Biosciences Corporation (U.S.) Recent Development
Table BIOVIEW Inc. (U.S.) Company Details
Table BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure BIOVIEW Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table BIOVIEW Inc. (U.S.) Recent Development
Table Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
Table Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
Table Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
Table Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
Table Digene Corporation (U.S.) Company Details
Table Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Digene Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Digene Corporation (U.S.) Recent Development
Table Gen-Probe Incorporated (U.S.) Company Details
Table Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Gen-Probe Incorporated (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table Gen-Probe Incorporated (U.S.) Recent Development
Table IVDiagnostics, Inc. (U.S.) Company Details
Table IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2014-2019)(Million US$)
Figure IVDiagnostics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2014-2019)
Table IVDiagnostics, Inc. (U.S.) Recent Development
Table Global Noninvasive Cancer Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Noninvasive Cancer Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Noninvasive Cancer Diagnostics Market Size Share by Regions in 2025
Figure United States Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Noninvasive Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Noninvasive Cancer Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Noninvasive Cancer Diagnostics Market Size by Product (2019-2025)
Figure Global Noninvasive Cancer Diagnostics Market Size by Product in 2025
Table Global Noninvasive Cancer Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Noninvasive Cancer Diagnostics Market Size by Application (2019-2025)
Figure Global Noninvasive Cancer Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs